Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jul 2019 11:34

RNS Number : 7376G
Cathay International Holdings Ld
25 July 2019
 

 25 July 2019

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

Cathay International Holdings Limited

("Cathay", the "Company" or the "Group")

Trading update

Hong Kong, 25 July 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"), provides a trading update for the six months ended 30 June 2019.

The Company expects a lower Group sales and profits in the first half 2019 than the same period last year.

As Lansen announced today in Hong Kong, Lansen expects to have noticeable decrease in its net profits for H1 2019 as compared with the net profit for H1 2018 due to the following reasons:

1. As stated in our 2018 annual report, Lansen has implemented a number of new strategic initiatives in its pharmaceutical business, in response to the challenging regulatory environment in China, by developing its own products such as Pafulin, Sicorten Plus, and certain featured pharmaceuticals; and reducing reliance on agency products. As a result, in the first half of the current financial year, Lansen's sales are below the same period last year.

2. A number of provisions and write-offs have been made against old and slow moving inventory.

3. As at 21 June 2019, Lansen decided not to exercise the put option (the "Put Option") to require Natural Dailyhealth to buy back its holding of 30% equity interest in Natural Dailyhealth. As a result, it has written off the related put option value.

Despite the short term impact on Lansen's results from the new strategic initiatives, Lansen sees improvement in its pharmaceutical segment and expects this segment's profit to be higher than that in same period last year, and looks forward to continuing improvement in the second half.

At Haizi, trading has been adversely impacted by a decrease in the market price for inositol and its results are expected to be below 2018.

Natural Dailyhealth and Botai are both trading broadly in line with expectations.

Our hotel remains profitable, although occupancy and average room rates are below last year and profits will be lower for the first half.

 

The Company's results for six months ended 30 June 2019 will be released in late August.

 

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

 

Tel: +852 2828 9289

Consilium Strategic Communications

Mary-Jane Elliott / Matthew Neal / Lindsey Neville

 

 

Tel: +44 (0) 203 709 5702

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKPDNKBKDDOB
Date   Source Headline
1st Dec 20205:39 pmRNSCompulsory Acquisition Notice
11th Nov 20209:46 amRNSResults of the Tender Offer
3rd Nov 202010:53 amRNSResult of SGM and Notification of change to Shares
3rd Nov 202010:08 amRNSLansen's seventh share reduction plan of Starry
2nd Nov 202010:11 amRNSDisposal of Starry Shares
29th Oct 202010:43 amRNSTotal Voting Rights
16th Oct 20206:16 pmRNSTender Offer and Notice of SGM
29th Sep 20201:14 pmRNSRequisition Notice
22nd Sep 202010:41 amRNSResults of Annual General Meeting
28th Aug 202012:10 pmRNSInterim Results
28th Aug 202011:57 amRNSNotice of AGM
27th Aug 20202:33 pmRNSLansen's Interim Results
21st Aug 202011:06 amRNSSecond Price Monitoring Extn
21st Aug 202011:00 amRNSPrice Monitoring Extension
14th Aug 20207:00 amRNSNotice of Interim Results 2020
3rd Aug 202011:21 amRNSBLOCK LISTING SIX MONTHLY RETURN
23rd Jul 20209:50 amRNSDisposal of Starry Shares
22nd Jul 202011:46 amRNSDisposal of Starry Shares
17th Jul 202012:12 pmRNSDisposal of Starry Shares
14th Jul 202010:09 amRNSTRANSFER OF LISTING
13th Jul 202011:17 amRNSPoll results of Lansen’s EGM
24th Jun 202010:46 amRNSDespatch of Circular by Lansen
15th Jun 202010:32 amRNSResult of General Meeting (“GM”)
5th Jun 20209:52 amRNSLansen update re Proposed Disposal
29th May 20202:18 pmRNSTotal Voting Rights
28th May 20202:49 pmRNSProposed transfer of listing and Notice of GM
21st May 20202:44 pmRNSTR-1: Notification of major holdings
20th May 20205:20 pmRNSTR-1: Notification of major holdings
18th May 20201:34 pmRNSDirector/PDMR Shareholding
24th Apr 20201:02 pmRNSPublication of Prospectus
21st Apr 20209:07 amRNSPublication and posting of Annual Report
9th Apr 202010:51 amRNSLansen's sixth share reduction plan of Starry
1st Apr 202010:39 amRNSAnnual Results for the year ended 31 December 2019
31st Mar 20202:37 pmRNSLansen reports annual results year ended 31 Dec 19
18th Mar 20207:00 amRNSNotice of Results
28th Feb 20207:00 amRNSTotal Voting Rights
11th Feb 20202:36 pmRNSTrading Update
3rd Feb 20207:00 amRNSBlock listing Six Monthly Return
30th Jan 20207:00 amRNSTreasury Shares,Share Capital,Total Voting Rights
27th Dec 20199:19 amRNSIncrease in shareholder loan
20th Dec 201911:36 amRNSUpdate re Board of Directors
12th Dec 201911:29 amRNSDisposal of Starry Shares
22nd Nov 201911:31 amRNSNew shareholder loan
31st Oct 20199:57 amRNSRetirement of an Executive Director
31st Oct 20197:12 amRNSTotal Voting Rights
30th Sep 20197:00 amRNSTotal Voting Rights
25th Sep 201910:36 amRNSDisposal of Starry Shares
18th Sep 201912:10 pmRNSDisposal of Starry Shares
11th Sep 201911:37 amRNSLansen's fifth share reduction plan of Starry
10th Sep 20193:10 pmRNSDisposal of Starry Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.